BIOLASE

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

BIOLASE reports strong Q1 performance, eyes profitability through market growth

BIOLASE's Q1 2024 earnings reflect a robust performance with growth in sales and improved financial metrics. The company's strategic focus on accelerating dental laser adoption and operational enhancements position it well for future success. While challenges exist in achieving profitability, BIOLASE's opportunities in the dental market and growth initiatives offer a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

Intuitive Education.Biolase.com Portal W ill Ensure Positive User Experience LAKE FOREST, Calif. , Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and educational initiatives with the launch of its new education web portal, Education.Biolase.com , which allows the Company to offer tailored education pathways through its new Waterlase Academy and Epic Diode Academy, which are designed to offer dental clinicians an easy-to-navigate solution to laser education.

BIOLASE FURTHER ENHANCES MARKET AWARENESS CAMPAIGN WITH THE MUCH ANTICIPATED LAUNCH OF NEW EDUCATION PORTAL

LAKE FOREST, Calif. , Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023.

BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE

LAKE FOREST, Calif. , Feb. 9, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022  honor by the Inland News Group.

BIOLASE RECEIVES SECOND TOP WORKPLACES 2022 AWARD

FOOTHILL RANCH, Calif. , Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary PIPStek LLC (Sonendo), to use patent litigation to try to save Sonendo's diminished position and reputation in the marketplace.

BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS

FOOTHILL RANCH, Calif. , Jan. 18, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between $14.0 million and $14.4 million, well above 2021 fourth quarter revenue of $12.4 million.

BIOLASE MAINTAINS POSITIVE MOMENTUM THROUGH YEAR END WITH SOLID FOURTH QUARTER REVENUE GROWTH; SIGNIFICANT MARKET OPPORTUNITY AND INDUSTRY-LEADING PRODUCT SUPPORT EXPECTATION FOR ROBUST REVENUE GROWTH IN 2023

LAKE FOREST, Calif. , Jan. 12, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces.

BIOLASE RECEIVES TOP WORKPLACES 2022 AWARD

LAKE FOREST, Calif. , Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre-funded warrant.

BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING

LAKE FOREST, Calif. , Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place December 1, 2022 in New York City.

BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York

BIOLASE, Inc. (NASDAQ:BIOL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Todd Kehrli - Investor Relations John Beaver - President and Chief Executive Officer Jennifer Bright - Chief Financial Officer Conference Call Participants Kyle Bauser - Lake Street Capital Markets Anthony Vendetti - the Maxim Group Bruce Jackson - The Benchmark Company Operator Good day and welcome to the BIOLASE Third Quarter 2022 Financial Results Conference Call. Please note, this call is being recorded.

BIOLASE, Inc. (BIOL) Q3 2022 Earnings Call Transcript

LAKE FOREST, Calif. , Nov. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2022.

BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE

LAKE FOREST, Calif. , Oct. 27, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE, Inc to Report Third Quarter 2022 Results on November 10, 2022

Dr. Morrow brings extensive clinical, dental and DSO experience to help expand laser adoption globally LAKE FOREST, Calif. , Oct. 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S.

BIOLASE NAMES DR. RUSSELL MORROW AS CHIEF DENTAL OFFICER

New application portal will help advance the submission, evaluation, and acceptance of laser research projects globally LAKE FOREST, Calif. , Oct. 5, 2022 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it is inviting clinicians and researchers from around the world to submit research proposals via the Research Grant Portal  at biolase.com/researchgrants.

BIOLASE LAUNCHES RESEARCH GRANT PORTAL TO ACCELERATE CLINICAL STUDIES ON INNOVATIVE DENTAL LASER TECHNOLOGY

LAKE FOREST, Calif. , Sept. 22, 2022 /PRNewswire/ --  BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has engaged Providence Film Group, a Valiant Eagle, Inc. (OTC: PSRU) subsidiary to produce a docuseries titled, "Talk Dental to Me.

BIOLASE DOCUSERIES, "TALK DENTAL TO ME" TO BE PRODUCED BY PROVIDENCE FILM GROUP

Waterlase Dental Laser Adoption Expected to Grow Among Dental Residency Programs  LAKE FOREST, Calif. , Aug. 31, 2022 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a strategic plan to partner with postgraduate dental specialty programs throughout North America, to expose new dentists to the benefits of Waterlase technology.

BIOLASE ANNOUNCES DEVELOPMENT OF STRATEGIC PLAN TO PARTNER WITH POSTGRADUATE DENTAL SPECIALTY PROGRAMS ACROSS THE U.S.

LAKE FOREST, Calif. , Aug. 24, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to present at the Lake Street 6th Annual Best Ideas Growth Conference being held September 14, 2022.

BIOLASE TO PARTICIPATE IN THE LAKE STREET 6TH ANNUAL BEST IDEAS GROWTH CONFERENCE SEPTEMBER 14, 2022

BIOLASE, Inc. (NASDAQ:BIOL ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Todd Kehrli - EVC Group John Beaver - President, CEO & Director Jennifer Bright - CFO Conference Call Participants Kyle Bauser - Lake Street Capital Markets Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capital Markets Operator Good day, and welcome to the BIOLASE Second Quarter 2022 Financial Results Conference Call. [Operator Instructions].

BIOLASE, Inc. (BIOL) CEO John Beaver on Q2 2022 Results - Earnings Call Transcript

LAKE FOREST, Calif. , Aug. 11, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30, 2022.

BIOLASE DELIVERS 34% REVENUE GROWTH YEAR OVER YEAR IN SECOND QUARTER

LAKE FOREST, Calif. , July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE, Inc to Report Second Quarter 2022 Results on August 11, 2022

Company continues to lead the dental laser industry with 302 issued and 31 pending patents LAKE FOREST, Calif. , July 25, 2022 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the company has received five new United States patents and seven new foreign patents in the last 12 months.

BIOLASE EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW UNITED STATES AND FOREIGN PATENTS

LAKE FOREST, Calif. , July 13, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a pilot program with Einstein Healthcare Network's residency in General Dentistry to train General Dentist residents in the use of Waterlase dental laser technology.

BIOLASE ANNOUNCES TRAINING INITIATIVE WITH EINSTEIN HEALTHCARE NETWORK'S GENERAL DENTISTRY RESIDENCY PROGRAM

LAKE FOREST, Calif., July 7, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the appointments of Jennifer Bright to Chief Financial Officer ("CFO") and Steven Sandor to Chief Operating Officer ("COO").

BIOLASE ANNOUNCES PROMOTIONS OF KEY TEAM MEMBERS

LAKE FOREST, Calif. , July 5, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a partnership today with TeamSmile.

BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM

LAKE FOREST, Calif. , June 30, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced that, on June 30, 2022, it entered into an amendment to its senior secured term loan with SWK Funding LLC.

BIOLASE ENTERS INTO FAVORABLE CREDIT AGREEMENT AMENDMENT

LAKE FOREST, Calif. , June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $6.5 million of its common stock and pre-funded warrants in a registered direct offering and warrants to purchase common stock in a concurrent private placement, priced at-the-market under Nasdaq rules.

News for BIOLASE Stock (BIOL)